Shaun Y P Ewe 1 , Robin G Abell 2 , Brendan J Vote 3 Show Affiliations »
Abstract
OBJECTIVE: We report a rare case of bilateral maculopathy that developed with the initiation of sertraline. METHODS: We conducted a case report and review of the literature. RESULTS: A 23-year-old man rapidly developed maculopathy with associated visual blurring after the initiation of sertraline. Treatment was ceased with the patient subsequently reporting mild improvement in visual symptoms. CONCLUSIONS: Maculopathy associated with sertraline use has yet to be established and recognized as an adverse side effect. With only one previous reported case in the literature, this condition requires further awareness. © The Royal Australian and New Zealand College of Psychiatrists 2014.
OBJECTIVE: We report a rare case of bilateral maculopathy that developed with the initiation of sertraline . METHODS: We conducted a case report and review of the literature. RESULTS: A 23-year-old man rapidly developed maculopathy with associated visual blurring after the initiation of sertraline . Treatment was ceased with the patient subsequently reporting mild improvement in visual symptoms . CONCLUSIONS: Maculopathy associated with sertraline use has yet to be established and recognized as an adverse side effect. With only one previous reported case in the literature, this condition requires further awareness. © The Royal Australian and New Zealand College of Psychiatrists 2014.
Entities: Chemical
Disease
Species
Keywords:
drug-induced; maculopathy; ocular toxicity; selective serotonin reuptake inhibitor; sertraline
Mesh： See more »
Substances： See more »
Year: 2014
PMID： 25358654 DOI： 10.1177/1039856214556327
Source DB: PubMed Journal: Australas Psychiatry ISSN： 1039-8562 Impact factor: 1.369